ArticleNCHS data brief2026
Abnormal Cholesterol in Children and Adolescents: United States, August 2021-August 2023.
Article in NCHS data brief, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This report provides the most recent prevalence estimates of abnormal blood cholesterol in children and adolescents ages 6-19 and describes changes in prevalences over time. Methods: Cholesterol, anthropometry, and demographics data from the National Health and Nutrition Examination Survey (NHANES) for 2013-2014 through August 2021-August 2023 were used for these analyses. Phlebotomy sample weights were used to estimate prevalence, and confidence intervals were estimated using Taylor series linearization. Statistically significant differences in prevalence estimates by age, sex, and weight status were tested using a t statistic at the p < 0.05 level, and trends were evaluated using linear regression models. Key Findings: During August 2021-August 2023, 16.5% of children and adolescents had at least one measure of abnormal cholesterol (high total cholesterol, low high-density lipoprotein cholesterol [HDL-C], or high non-HDL-C). The prevalence of at least one abnormal cholesterol measure was lower in girls (13.6%) than in boys (19.2%) and lower in those with underweight or normal weight (10.3%) or overweight (11.5%) than in those with obesity (35.8%). The prevalence of at least one abnormal cholesterol measure decreased between 2013-2014 (21.3%) and August 2021-August 2023 (16.5%).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.